Xin Lang Cai Jing·2025-10-17 03:17Core Viewpoint - Kanglong Chemical experienced a decline in stock price by 2.03% on October 17, 2023, with a current price of 30.45 CNY per share and a total market capitalization of 54.146 billion CNY [1] Group 1: Stock Performance - Year-to-date, Kanglong Chemical's stock price has increased by 19.41%, but it has seen a decline of 7.95% over the last five trading days and 6.22% over the last twenty days [1] - The stock's performance over the last sixty days shows an increase of 15.30% [1] Group 2: Financial Performance - For the first half of 2025, Kanglong Chemical reported a revenue of 6.441 billion CNY, representing a year-on-year growth of 14.93%, while the net profit attributable to shareholders decreased by 37.00% to 701 million CNY [2] - Since its A-share listing, the company has distributed a total of 1.794 billion CNY in dividends, with 1.007 billion CNY distributed over the last three years [3] Group 3: Shareholder Information - As of June 30, 2025, the number of shareholders for Kanglong Chemical increased by 10.12% to 87,900 [2] - The top ten circulating shareholders include notable funds such as China Europe Medical Health Mixed A and Hong Kong Central Clearing Limited, with varying changes in their holdings [3] Group 4: Business Overview - Kanglong Chemical, established on July 1, 2004, and listed on January 28, 2019, specializes in drug research, development, and production services [1] - The company's revenue composition includes laboratory services (60.43%), CMC services (21.58%), clinical research services (14.58%), and other services [1]